title: [Current status of chemotherapy for renal cell carcinoma].
abstract: Renal cell carcinoma has been considered a tumor highly insensitive to conventional chemotherapy because of its multivariate biological potential, delayed manifestation of clinical symptoms and the lack of systematic investigation. In this respect, recent advances in pharmacological and pharmaceutical technology promise to be very effectively applied in chemotherapy for this tumor.
authors.affiliation: Dept. of Urology, Akita University School of Medicine.
authors.forename: T
authors.initials: T
authors.lastname: Kato
authors.forename: K
authors.initials: K
authors.lastname: Sato
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy*; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage; D012074:Remission Induction
chemical_list: D017258:Medroxyprogesterone Acetate; D005472:Fluorouracil